News
| NYSE:ABBV | Press Release | AbbVie Inc.
stockhouse.com
21 hours ago — ... without disease progression," said Mohamed Zaki, M.D., Ph.D., vice president and global head of oncology clinical development, AbbVie. › press-releases ›
AbbVie (ABBV) Presents Investigational Navitoclax ...
www.streetinsider.com
16 hours ago — "Current treatment options for myelofibrosis are limited and targeted toward controlling disease symptoms," said Mohamed Zaki, M.D., Ph.D., ... › Corporate+News › Abb...
sorted by relevance / date